Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 191-200 of 845 for cardiovascular

Edit search filters
  1. A Study to Evaluate the Safety and Tolerability of LCZ696 Followed by a 52-week Study of LCZ696 Compared With Enalapril in Pediatric Patients with Heart Failure

    Rochester, MN

  2. Healthy Immigrant Community: Mobilizing the Power of Social Networks

    Rochester, MN

  3. A Study of the Effects of Decreasing the Lasix Dose on the Cardiorenal System

    Rochester, MN

  4. Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction

    Scottsdale/Phoenix, AZ

  5. PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial

    Scottsdale/Phoenix, AZ

  6. Low Cost QTc Meter for Long QT Syndrome Screening in Primary Care

    Rochester, MN

  7. A Study for the Development of a Low Cost QTc Meter for Long QT Syndrome Screening in Primary Care

    Rochester, MN

  8. Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI)

  9. The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis

    Jacksonville, FL, Rochester, MN

  10. Grit as a Predictor of Outcomes in Transcatheter Valvular Therapeutic Candidates

.

Mayo Clinic Footer